Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Prevention and nonsurgical treatment options to prevent low back pain and protect spine

Back and neck problems can be caused by a herniated disc, spinal stenosis, injury, strain or osteoarthritis. "Although more than 75 percent of Americans will experience some back pain during their lifetime, about 90 percent of cases are resolved without surgery," stated John K. Ratliff, MD, FACS, a Philadelphia spine surgeon and American Association of Neurological Surgeons spokesperson.

24 Apr 2010

New ways for earlier diagnosis of osteoarthritis

Researchers at King's College London's Department of Twin Research and Genetic Epidemiology, based at St Thomas' Hospital have discovered new ways of measuring biological markers in the blood which could be used to diagnose osteoarthritis earlier.

23 Apr 2010

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Abbott today announced financial results for the first quarter ended March 31, 2010.

21 Apr 2010

New nanotechnology biomedical therapy for joint injuries

Dr. Nirav A. Shah, MD, an orthopaedic sports medicine surgeon affiliated with Palos Community Hospital is the first to design a new nanotechnology biomedical therapy that promotes the growth of new, stronger cartilage to aid in the treatment of joint injuries.

16 Apr 2010

Moving is the best medicine for arthritic pain

The burden of arthritis is greater for African Americans and Hispanics, despite lower prevalence among these groups according to a Centers for Disease Control and Prevention (CDC) report published in the May issue of Preventing Chronic Disease.

16 Apr 2010

Articulinx closes $10M Series B financing round

Articulinx, Inc., a medical device company developing a novel minimally-invasive approach for the treatment of osteoarthritis, announced today the closing of a $10M Series B financing led by US Venture Partners (USVP).

15 Apr 2010

ConforMIS' iUni G2 patient-specific knee replacement system receives CE Mark certification

ConforMIS, Inc. announced today that the iUni® G2 has received CE Mark certification, providing regulatory approval for ConforMIS to begin the sale of this products throughout the European Union. The iUni G2 is the next generation of ConforMIS' revolutionary patient-specific knee replacement system, and remains the only patient-specific unicompartmental knee resurfacing implant on the market.

15 Apr 2010

XOMA expands anti-inflammatory antibody intellectual property portfolio

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Patent and Trademark Office has issued two new patents that significantly expand the company's intellectual property portfolio relating to its anti-inflammatory antibody, XOMA 052, that targets interleukin-1 beta (IL-1 beta).

13 Apr 2010

Oceana Therapeutics, Q-Med submit Solesta PMA application for treatment of fecal incontinence

Oceana Therapeutics and Q-Med AB today announced the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for Solesta® for the treatment of Fecal (or Bowel) Incontinence, a largely unsatisfied medical need afflicting millions of Americans.

12 Apr 2010

Meltdown Station provides educational material to help children learn healthy lifestyle skills

With the childhood obesity epidemic finally at the front line, first lady Mrs. Obama has taken the initiative to do something about it, but what is she doing? The first lady Mrs. Obama started the Let's Move! Initiative and stated in a press conference "that the goal of the program is to reverse the trend toward childhood obesity in one generation."

8 Apr 2010

AHRQ: Women accounted for nearly 60% of 39.4M admissions to U.S. hospitals in 2007

Women accounted for nearly 60 percent of the 39.4 million admissions to U.S. hospitals in 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

7 Apr 2010

Leg length inequality linked to osteoarthritis: Study

A new study shows that arthritis in the knee is linked to the common trait of having one leg that is longer than the other. Whether or not leg length differential is a direct cause of osteoarthritis is not clear, but the findings may allow people to take preventive measures before the onset of the chronic and painful condition.

1 Apr 2010

Positive results from Phase 2 clinical trial of OMS103HP

Omeros Corporation today announced that a Phase 2 clinical trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, demonstrated that patients treated with OMS103HP during arthroscopic knee meniscectomy surgery achieved statistically significant clinical benefits.

1 Apr 2010

New anti-inflammatory drug shows promise for treating inflammatory disorders

Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) remain the most common treatment to relieve symptoms of arthritis and other inflammatory disorders. But despite their widespread use (around 2.5 million Canadians have osteoarthritis) these medications are also known to cause severe, sometimes life-threatening adverse effects within the body, particularly in the gastrointestinal tract

31 Mar 2010

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.

31 Mar 2010

Study: Hormone replacement in joint fluid might be beneficial in treating osteoarthritis

German researchers determined that concentrations of the sex hormones, testosterone in men and estrogen in women, may have a positive effect on the regenerative potential of cartilage tissue. The study suggests hormone replacement in the joint fluid of men and women might be beneficial in treating late stages of human osteoarthritis by regenerating damaged tissue.

30 Mar 2010

Flip-flops and sneakers may help reduce osteoarthritis

Flip-flops and sneakers with flexible soles are easier on the knees than clogs or even special walking shoes, a study by Rush University Medical Center has found. And that's important, because loading on the knee joints is a key factor in the development of osteoarthritis.

25 Mar 2010

Hospital costs for treating septicemia increased from $4.1 billion in 1997 to $12.3 billion in 2007

The hospital costs for treating septicemia increased by an average of nearly 12 percent each year from 1997 to 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Treating this potentially deadly blood infection increased from $4.1 billion in 1997 to $12.3 billion in 2007.

20 Mar 2010

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.

19 Mar 2010

Liquid CMO seeks osteoarthritis and fibromyalgia patients for pilot study in Phoenix

Makers of a new liquid natural supplement formulation of Cetyl-Myristoleate (CMO) are seeking osteoarthritis and fibromyalgia patients for a pilot study in Phoenix beginning Monday, April 12, 2010.

16 Mar 2010

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Prevention and nonsurgical treatment options to prevent low back pain and protect spine

New ways for earlier diagnosis of osteoarthritis

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

New nanotechnology biomedical therapy for joint injuries

Moving is the best medicine for arthritic pain

Articulinx closes $10M Series B financing round

ConforMIS' iUni G2 patient-specific knee replacement system receives CE Mark certification

XOMA expands anti-inflammatory antibody intellectual property portfolio

Oceana Therapeutics, Q-Med submit Solesta PMA application for treatment of fecal incontinence

Meltdown Station provides educational material to help children learn healthy lifestyle skills

AHRQ: Women accounted for nearly 60% of 39.4M admissions to U.S. hospitals in 2007

Leg length inequality linked to osteoarthritis: Study

Positive results from Phase 2 clinical trial of OMS103HP

New anti-inflammatory drug shows promise for treating inflammatory disorders

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

Study: Hormone replacement in joint fluid might be beneficial in treating osteoarthritis

Flip-flops and sneakers may help reduce osteoarthritis

Hospital costs for treating septicemia increased from $4.1 billion in 1997 to $12.3 billion in 2007

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Liquid CMO seeks osteoarthritis and fibromyalgia patients for pilot study in Phoenix

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in